The CD20 inhibitor Ocrevus (ocrelizumab) rapidly depletes immune B-cells in people with multiple sclerosis (MS), as expected, but ongoing treatment also leads to changes in immune T-cells, a new study […] The post Ocrevus rapidly depletes B-cells, then alters T-cells in MS patients appeared first…
Octave Bioscience has raised $35.6 million in funding to continue marketing its multiple sclerosis (MS) disease activity test and accelerate the development of a similar tool for Parkinson’s disease. The […] The post New blood test for MS receives major commercialization funding appeared first on…
Tweet A recent US multi-center study involving over 1,400 patients with multiple sclerosis (MS) has found that those treated with rituximab experienced significantly higher rates of hospitalizations, infections, and hypogammaglobulinemia compared to patients on ocrelizumab. The study analyzed data from UCSF and a larger University…
Three biosimilar drugs — approved versions of brand-name therapies that have no clinically meaningful differences compared with their reference products — including one for multiple sclerosis (MS), will soon be […] The post New partnership bringing MS biosimilar drug to MENA region appeared first on…
Tweet This paper looks at the outcome of HSCT in the United Kingdom and I guess one question is what DMT can compare? NEDA is no relapse no progression and no MRI so how does the good news on no relapse, no progression and no…
Multiple Sclerosis has taken a lot from me over the past 25 years. Building connections and relationships with elected officials, like with our State Senator Roger Hauck, is one way ennifer and I are using our voices following our MS diagnoses. I mean, I could’ve…
Tweet If you can cast your mind back to ECTRIMS 2016 in London…We were sat outside the Excel Centre in London making our poster for the next days poster session we had some helium balloons saying 95 percent, which was the number of people that…
Tweet Neurofilament is a marker of `nerve damage and so can spot sub clinical attacks, we have been using this for years to help detect active disease. somet;imes lesions cant be seen on MRI, van Pamelen J, Koel-Simmelink MJA, Lissenberg BI, Arnoldus EPJ, de Beukelaar…
Our blog theme this month is transitions, and that feels very appropriately timed for me. My kids are back in school (HOW IS MY BABY IN 1st GRADE?!) and I’ve recently found myself single. So, this is a tough post … Continue reading → Source:…
Most children with multiple sclerosis (MS) have chronic active lesions that slowly get bigger over time, and their frequency seems to correlate with the total number of lesions and reduced […] The post Study finds most children with MS have slow-growing brain lesions appeared first…